MedImmune Inc., Micromet AG preclinical data

Researchers published in Cancer Immunology Immunotherapy that 0.06 µg/kg of MT103 led to fully reversible activation of T cells in chimpanzees. Also, repeated short-term exposure of MT103 led to a cum...